Skip to main content
SpringerLink
Log in

Malignes Melanom: Nebenwirkungen der Immuncheckpointblockade

Häufigkeit kardialer, neurologischer und autoimmuner Nebenwirkungen

  • Fortbildung
  • Published:
hautnah dermatologie Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Arnold M et al. Global burden of cutaneous melanoma in 2020 and projections to 2040. JAMA Dermatol 2022; 158:495-503

  2. Laenens D et al. Incidence of cardiovascular events in patients treated with immune checkpoint inhibitors. J Clin Oncol 2022;40:3430-8

  3. Naqash AR et al. Major adverse cardiac events with immune checkpoint inhibitors: A pooled analysis of trals sponsored by the National Cancer Institute - Cancer Therapy Evaluation Program. J Clin Oncol 2022;40:3439-52

  4. Michel L et al. Targeting early stages of cardiotoxicity from anti-PD1 immune checkpoint inhibitor therapy. Eur Heart J 2022;43:316-29

  5. Wang DY et al. Fatal Toxic effects associated with immune checkpoint inhibitors: a systematic review and meta-analysis. JAMA Oncol 2018;4:1721-8

  6. Farooq MZ et al. Association of immune checkpoint inhibitors with neurologic adverse events: A systematic review and meta-analysis. JAMA Netw Open 2022;5:e227722

  7. Owen CN et al. Delayed immune-related adverse events with anti-PD-1-based immunotherapy in melanoma. Ann Oncol 2021;32:917-25

  8. Tan AC, Emmett L, Lo S, Liu V, Kapoor R, Carlino MS, Guminski AD, Long GV, Menzies AM, FDG-PET response and outcome from anti-PD-1 therapy in metastatic melanoma. Ann Oncol 2018;29:2115-20

Download references

Author information

Authors and Affiliations

  1. Klinik für Dermatologie/Allergologie, Universiätsklinikum Schleswig-Holstein - Campus Kiel -, Arnold-Heller-Str. 3, 24105, Kiel, Deutschland

    Axel Hauschild

Authors
  1. Axel Hauschild
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Axel Hauschild.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hauschild, A. Malignes Melanom: Nebenwirkungen der Immuncheckpointblockade. hautnah dermatologie 39 (Suppl 1), 28–33 (2023). https://doi.org/10.1007/s15012-023-7669-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15012-023-7669-9

Search

Navigation